Qualitek Labs Ltd

Qualitek Labs Expands Pan-India Presence with Strong Revenue & Margin Growth 📈

- Consolidated revenue for FY 2025-26: ₹125 Crore (4x increase over FY24).

- H2 FY26 consolidated EBITDA: ₹18.1 Cr (102% YoY growth, 26% margin).

- H2 FY26 consolidated PAT: ₹9.8 Cr (143% YoY growth, 14% margin).

- Standalone H2 FY26 revenue: ₹38.6 Cr (55% YoY growth).

- Pan-India network: 10 owned labs + 6 PPP labs, 1,200+ employees.

- FY 2025-26 Capex: ₹51.3 Cr (acquisitions, lab expansions, new facilities).

- FY 2026-27 Capex plan: ₹63 Cr (focus on Pharma, Food, Electricals & Electronics).

- Lab space growth: 25K Sq. Ft. (2018) → 290K Sq. Ft. (2026).

- Revenue CAGR (2020-2026): 77%.

- Serves 5,000+ customers across Automotive, Defence, Pharma, and Food Testing sectors.

- Medium-term goal: Become a leading global lab by 2031-32 via geographic expansion & M&A.